1. Home
  2. TLYS vs ATOS Comparison

TLYS vs ATOS Comparison

Compare TLYS & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$5.05

Market Cap

43.3M

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$4.96

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
ATOS
Founded
1982
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
36.2M
IPO Year
2011
2010

Fundamental Metrics

Financial Performance
Metric
TLYS
ATOS
Price
$5.05
$4.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$2.00
$23.00
AVG Volume (30 Days)
2.2M
69.1K
Earning Date
03-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
N/A
EPS
N/A
N/A
Revenue
N/A
$1,758.00
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
$17.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.53
52 Week High
$5.22
$7.56

Technical Indicators

Market Signals
Indicator
TLYS
ATOS
Relative Strength Index (RSI) 90.15 51.86
Support Level $1.38 $4.59
Resistance Level N/A $5.12
Average True Range (ATR) 0.37 0.42
MACD 0.04 -0.09
Stochastic Oscillator 90.03 24.00

Price Performance

Historical Comparison
TLYS
ATOS

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: